Therefore, in this study, we evaluated whether the circulating levels of TNFR1, TNFR2, and PGRN, in addition to interleukin 6 (IL-6) and CRP, are associated with disease severity and mortality in 80 hospitalized COVID-19 patients. The gene discussed is IL6; the disease is COVID-19.